maps bulletin - volume xiv - number 1 - summer 2004
< Return to Table of Contents
New Ibogaine Documentary: An appeal for funds
by Ben de Loenen

Derived from the root of the African plant Tabernanthe iboga, which grows in Gabon, ibogaine was originally used during initiations of the Bwiti culture. In the 1960s, the anti-addictive properties of this psychoactive substance were discovered by Howard Lotsof. Since then, ibogaine has been surrounded by controversy. The decisions about the use of ibogaine in the treatment of addiction appear to have been made on a political and economical, rather than rational basis.

I have always been very interested in addiction and other social problems. I started researching ibogaine two years ago, and developed a concept for a documentary- Retrospection on the Future-for my final exam project for the Utrecht School of the Arts in Holland. Since then the project has grown significantly, to the point where it has become a professional production. During these two years of hard work, it became clear to me that ibogaine is something people should know about. In the media, ibogaine has so far been portrayed as either a miracle cure or a dangerous hallucinogen. By showing the different aspects related to ibogaine I want to invite the viewer to form his or her own opinion on the subject.

This film project will visualize the diversity of ibogaine uses by showing personal experiences from the Iboga Therapy House in Vancouver, the Ibogaine Association in Mexico, and Sara's House in Holland, as well as the traditional initiations in Gabon. The film includes interviews with scientists, treatment providers, ex-addicts, parents and the Bwiti community. It offers an intriguing, personal insight into the lives of different addicts during their life-transforming process. Even more unique, we will show the opinion of the Bwiti people on the use of ibogaine in the Western world, something that has never been brought into the discussion around the subject.

Of the three shooting periods for the film-one in Holland and France, one in Mexico, Canada, and the U.S., and one in Africa-the first two are complete. During the first shooting period we filmed a treatment at Sara's House, close to Amsterdam. We also interviewed several people, including Howard Lotsof and the Dutch addiction expert Peter Cohen. In Paris we interviewed a famous Gabonese Nganga (shaman) called Mallendi, who has initiated about a thousand people so far. During the second shooting period we filmed one treatment in Mexico at the Ibogaine Association and one in Vancouver at the Iboga Therapy House. We also conducted interviews-in San Diego, Vancouver, New York, Albany, Miami, Gainesville and Sarasota-with the treatment providers Randy Hencken, Sandra Karpetas, and Eric Taub; scientists such as Stanley Glick and Kenneth Alper; ex-addicts; the father of an ex-addict; and a psychotherapist. The shooting period in Africa is planned for July, but a lot of production work still needs to be done, and the most urgent issue is funding. We already have the cooperation of the local people; they are proud of their culture and have a lot to say to the Western world. There is a young African woman who has agreed on being filmed during her initiation. Now we need to obtain the funding to make this possible. To do that we still need about $3500 to pay for the flights, the equipment rentals, food, and permits. The film has become very important to addicts who want to change their lives, the people that conduct research and treatment with ibogaine, and of course myself. My goal is to distribute the film internationally, so as many people as possible will learn about this substance. Tax-deductible donations to MAPS can be made for this project. *

 
 
< Return to Table of Contents: Summer 2004 Issue - "10 stamps and $250,000"
 
Spring 2010 Vol. 20, No. 1 Special Edition: Psychedelics, Death and Dying
Autumn 2009 Vol. 19, No. 3 MAPS Financial Report: Fiscal Year 2008-09
Summer 2009 Vol. 19, No. 2 MAPS Research Update 2009
Spring 2009 Vol. 19, No. 1 Special Edition: Psychedelics and Ecology
Winter 2008/09 Vol. 18, No. 3 MAPS 2008 Financial Report
Summer 2008 Vol. 18, No. 2 Phoenix Rising: A Review of MAPS Research
Spring 2008 Vol. 18, No. 1 Special Edition: Technology and Psychedelics
Winter 2007 Vol. 17, No. 3 MAPS 06-07 Fiscal Yearly Report
Autumn 2007 Vol. 17, No. 2 Special Edition: Psychedelics and Self-Discovery
Spring/Summer 2007 Vol. 17, No. 1 The Chrysalis Stage
Winter 2006-7 Vol. 16, No. 3 Low Maintenance/High Performance
Autumn 2006 Vol. 16, No. 2 Technologies of Healing
Spring 2006 Vol. 16, No. 1 MAPS' 20th Anniversary
Winter 2005 Vol. 15, No. 3 MAPS final year as a teenager
Summer 2005 Vol. 15, No. 2 Israel Conference: MDMA/PTSD Research
Spring 2005 Vol. 15, No. 1 Accelerating flow of work and time
Autumn 2004 Vol. 14, No. 2 Rites of Passage: Kids and Psychedelics
Summer 2004 Vol. 14, No. 1 10 stamps and $250,000
Winter 2003 Vol. 13, No. 2 Holy Fire
Spring 2003 Vol. 13, No. 1 60th Anniversary of the Discovery of LSD
Autumn 2002 Vol. 12, No. 3 Vision
Summer 2002 Vol. 12, No. 2 "From celebration to frustration, and back again."
Spring 2002 Vol. 12, No. 1 Sex, Spirit & Psychedelics 2002
Autumn 2001 Vol. 11, No. 2 "In the future, it will be called Despair."
Spring 2001 Vol. 11, No. 1 "A Tidal Wave of Ecstasy!"
Autumn 2000 Vol. 10, No. 3 Creativity 2000
Summer 2000 Vol. 10, No. 2 Endings and Beginnings
Spring 2000 Vol. 10, No. 1 Making History in Slow Motion
Winter 1999/00 Vol. 9, No. 4 To the Ends of the Earth for MDMA Research...
Autumn 1999 Vol. 9, No. 3 MAPS' long-standing efforts to conduct...
Summer 1999 Vol. 9, No. 2 MAPS has come full circle...
Spring 1999 Vol. 9, No. 1 Patience, persistence and passion
Winter 1998/99 Vol. 8, No. 4 One of special pleasures of directing MAPS...
Autumn 1998 Vol. 8, No. 3 The Ayahuasca Issue (with Hofmann interview)
Summer 1998 Vol. 8, No. 2 Emotionally Powerful Anecdotes...
Spring 1998 Vol. 8, No. 1 Death Has a Way of Focusing One's Attention
Autumn 1997 Vol. 7, No. 4 Celebration is in Order
Summer 1997 Vol. 7, No. 3 Time Horizons
Spring 1997 Vol. 7, No. 2 Synchronicity
Winter 1996/97 Vol. 7, No. 1 Learning to Crawl
Autumn 1996 Vol. 6, No. 4 An Invitation for Dialogue
Summer 1996 Vol. 6, No. 3 Budding Research
New Year 1996 Vol. 6, No. 2 Sending Down Roots
Autumn 1995 Vol. 6, No. 1 Baby Steps
Summer 1995 Vol. 5, No. 4 Opportunity Amidst Obstacles
Winter 1994/95 Vol. 5, No. 3 Clinical Trials and Tribulations
Autumn 1994 Vol. 5, No. 2 Building Towards Clinical Trials
Summer 1994 Vol. 5, No. 1 Politics and Protocols: In Search of a Balance
Spring 1994 Vol. 4, No. 4 Laying the Groundwork
Winter 1993/94 Vol. 4, No. 3 A Time of Tests
Summer 1993 Vol. 4, No. 2 So Close Yet So Far
Spring 1993 Vol. 4, No. 1 Remembrance and Renewal
Winter 1992/93 Vol. 3, No. 4 Forging New Alliances
Summer 1992 Vol. 3, No. 3 Building on Common Ground
Spring 1992 Vol. 3, No. 2 Small Steps, Gradual Progress, New Opportunities
Winter 1991/92 Vol. 3, No. 1 The Rekindling of a Thousand Points of Light
Summer 1991 Vol. 2, No. 2 MDMA protocol development with cancer patients
Winter 1990/91 Vol. 2, No. 1 MAPS' Swiss pharmacologically-assisted psychotherapy conference
Autumn 1990 Vol. 1, No. 3 What and Who is MAPS?
Summer 1989 Vol. 1, No. 2 Switzerland Leads the Way
Summer 1988 Vol. 1, No. 1 MDMA can become a legal medicine